New Ebola vaccination study looks like a breakthrough.
The latest findings could change how we protect at-risk people. Questions remain.
Related Articles
Subscribe to Inside Medicine
Merging what I’m seeing in the ER with rigorous deep-dives on the very latest medical and public health data. I want you to know what…
Subscribe to Inside Medicine
Merging what I’m seeing in the ER with rigorous deep-dives on the very latest medical and public health data. I want you to know what…
Data Snapshot: The eyes have it.
In the spring, tree pollen makes life pretty miserable for those of us who are seasonal allergy sufferers. Two years ago, I did an interview…
How to view the solar eclipse with maximum safety and awe.
Should you take a photograph? Can you use binoculars? We’ve got answers. Plus, why this eclipse has special meaning for eclipse scientists and enthusiasts.
New research: Razor thin margins at best on prostate cancer screening benefits.
Prostate cancer screening should work better than it does. By measuring prostate specific antigen (PSA) levels in the blood, doctors should be able to detect…
How to view the solar eclipse with maximum safety and awe.
Should you take a photograph? Can you use binoculars? We’ve got answers. Plus, why this eclipse has special meaning for eclipse scientists and enthusiasts.
How to view the solar eclipse with maximum safety and awe.
Should you take a photograph? Can you use binoculars? We’ve got answers. Plus, why this eclipse has special meaning for eclipse scientists and enthusiasts.
Inside Medicine: Five on Friday (April 5, 2024).
This week in medicine, what I’m thinking about, etc. You know, an actual newsletter.
Paxlovid does not reduce symptoms, definitive Pfizer trial finds.
Pfizer finally published its study of Paxlovid’s effects on symptoms for standard-risk and high-risk vaccinated patients with Covid-19. No difference in symptoms. The upshot of…